The development of the initiating transcription factor binding site led to an increase in TERT expression, telomerase activation in the TERTp mutant GBM, and ALT in the IDH mutant GBM as a result of the concurrent loss of ATRX function or mutation 55, 128. This evidence concerns the gene ATRX and glioblastoma.